Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of CHOP With or Without Rituximab in Older Patients With Non-Hodgkin's Lymphoma
NCT00003150Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Dec 1997
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in non-Hodgkin lymphoma (NHL), sponsored by Eastern Cooperative Oncology Group. Started Dec 1997; status: completed.
02
Drugs
rituximab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00003150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003150.